This inventor holds 1 USPTO granted patent. Top assignee: Roussel Uclaf. Active years: 1984.
Company Filing History:
Years Active: 1984
Title: The Innovations of Frederick L Parker
Introduction
Frederick L Parker is a notable inventor based in Swindon, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative patent related to imidazoquinoxalines. His work has implications for the development of new medications with antiallergic properties.
Latest Patents
Frederick L Parker holds a patent for "4,5-Dihydroimidazo-[1,2-a]quinoxaline-2-carboxylic acids and their novel imidazoquinoxalines." This patent describes a complex chemical structure with various functional groups that can be utilized in pharmaceutical applications. The invention focuses on compounds that exhibit antiallergic properties, which could lead to advancements in allergy treatments.
Career Highlights
Parker is associated with Roussel Uclaf, a company known for its research and development in the pharmaceutical industry. His work at Roussel Uclaf has allowed him to explore innovative solutions to medical challenges. With a patent portfolio that includes one significant patent, he has established himself as a valuable contributor to the field.
Collaborations
Frederick L Parker has collaborated with notable colleagues such as Alan C Barnes and David P Kay. These collaborations have likely enriched his research and contributed to the successful development of his patented inventions.
Conclusion
Frederick L Parker's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to impact allergy treatments significantly.